Status:

UNKNOWN

Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH

Lead Sponsor:

University of Sheffield

Collaborating Sponsors:

GlaxoSmithKline

Conditions:

Pulmonary Arterial Hypertension

Eligibility:

All Genders

Phase:

NA

Brief Summary

Pulmonary arterial hypertension (PAH) is progressive life limiting disease with a median survival of less than 3 years without treatment. Current drug trials in PAH commonly use simple tests for examp...

Detailed Description

Background: Pulmonary arterial hypertension (PAH) is a rare but severe and progressive disorder, with a prevalence of approximately 50 in 1,000,000 of the population. The condition is incurable with ...

Eligibility Criteria

Inclusion

  • Patients with PAH
  • PAH subject is diagnosed with Group 1 pulmonary arterial hypertension, including IPAH, hereditable and CTD, and PAH associated with portal hypertension
  • Mean pulmonary arterial pressure ≥ 25 mmHg
  • Pulmonary arterial wedge pressure ≤ 15 mmHg

Exclusion

  • Inability to perform the study protocol
  • Significant comorbidity where in the opinion of the clinician this is a significant contributor to the patients PAH
  • Pregnancy
  • Allergy to contrast medium
  • Contraindication to MRI (as per standard screening questionnaire)
  • Significant lung disease.
  • Known Hep B,C, HIV
  • Healthy volunteers
  • Inclusion criteria:
  • Male or female aged between 18 years and 60 years
  • Currently healthy as determined by a responsible physician
  • No significant history of lung or cardiac disease and normal BNP.
  • Capable of giving written informed consent.
  • Subject is \>50kg with a body mass index within the range 18.0 to 32kg/m2.

Key Trial Info

Start Date :

September 15 2015

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

May 20 2019

Estimated Enrollment :

44 Patients enrolled

Trial Details

Trial ID

NCT03841344

Start Date

September 15 2015

End Date

May 20 2019

Last Update

February 18 2019

Active Locations (0)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 0 (0 locations)

No Results Found

We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.

Repeatability and Sensitivity to Change of Non-invasive Endpoints in PAH | DecenTrialz